treatment of patients with metastatic colorectal cancer / treatment of metastatic colorectal cancer / oncology drug marketing applications / therapy for Metastatic Colorectal Cancer / therapy of metastatic colorectal cancer / treatment of breast cancer / Therapy For Colorectal Cancer / treatment of postmenopausal women with advanced breast cancer / Treatment for Recurrent Metastatic Colorectal Cancer / therapies for colorectal cancer / Treatment of Colon Cancer / treatment of advanced colon cancer / treatment of colorectal cancer / /
MedicalCondition
common cancers / leukemia / tumor / cancer / Kaposi's sarcoma / colorectal cancer / resected colorectal cancer / refractory tumors / highly toxic cancer / C colon cancer / pulmonary symptom benefit / hematologic malignancies / metastatic colorectal cancer / lymphomas / pancreatic cancers / colon cancer / pain / lung cancer / advanced colon cancer / leukemias / each cancer / advanced breast cancer / infections / breast cancer / anemia / pancreatic cancer / few existing cancer / /
National Cancer Institute / Food and Drug Administration / FDA / Oncologic Drugs Advisory Committee / Division of Oncology Drug Products / American Association for Cancer Research / American Society of Clinical Oncology / /
Product
cisplatin / camptosar / Oncology Drug / CPT-11 / /
FDA Background for Colon Cancer Endpoints Workshop